Open access
Sep 2026
Spread potential and architectural variant of a multiple-drug resistant Escherichia coli co-producing lipopolysaccharide-modifying determinants and extended-spectrum β-lactamases
Background Abuse of β-lactam antibiotics and its spread of drug resistance challenged the applicability of antimicrobial agents, enabling polymyxins as a last-line treatment for anti-infections of multi-drug resistant (MDR) pathogen. Polymyxin is applicable to herb breeding/growth prompting and combatting Gram-negative...
Shuang Wan, Tao Huang, Jun Li et al.
· Frontiers in Microbiology · 0 citations